Net profit of Poly Medicure rose 16.24% to Rs 68.36 crore in the quarter ended March 2024 as against Rs 58.81 crore during the previous quarter ended March 2023. Sales rose 23.21% to Rs 378.07 crore in the quarter ended March 2024 as against Rs 306.85 crore during the previous quarter ended March 2023.For the full year,net profit rose 44.05% to Rs 258.26 crore in the year ended March 2024 as against Rs 179.28 crore during the previous year ended March 2023. Sales rose 23.36% to Rs 1375.80 crore in the year ended March 2024 as against Rs 1115.23 crore during the previous year ended March 2023. ParticularsQuarter EndedYear Ended�Mar. 2024Mar. 2023% Var.Mar. 2024Mar. 2023% Var. Sales378.07306.85 23 1375.801115.23 23 OPM %25.5527.12 -26.0423.80 - PBDT108.6689.94 21 408.20294.66 39 PBT92.4675.16 23 344.27237.49 45 NP68.3658.81 16 258.26179.28 44 Powered by Capital Market - Live News

Poly Medicure will hold a meeting of the Board of Directors of the Company on 17 May 2024.Powered by Capital Market - Live News

The Board of Poly Medicure at its meeting held on 08 March 2024 has approved raising of funds for an aggregate amount not exceeding Rs 800 crore via debt issuance in one or more tranches. Powered by Capital Market - Live News

Poly Medicure will hold a meeting of the Board of Directors of the Company on 8 March 2024.Powered by Capital Market - Live News

Poly Medicure has allotted 26,375 equity shares under ESOP. The issued and paid-up equity share capital stands increased to Rs. 47,98,53,585 divided into 9,59,70,717 equity shares of face value of Re. 5/- each on 13 February 2024.Powered by Capital Market - Live News